Effects of Anti-Diabetic Drugs on Satellite Cell Function: A Mini Review
Metformin, glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) and sodium glucose cotransport 2 inhibitors (SGLT2i) are the most frequently prescribed medications for the treatment of diabetes. While the efficacy of these anti-diabetic drugs is clear, the underlying mechanisms of how they improve metabolism and produce other seemingly beneficial off-target effects are not clear. Several tissues including skeletal muscle have been implicated in the on-target and off-target actions of these drugs. Satellite cells are muscle stem cells that are important for skeletal muscle adaptation to stimuli such as exercise. In this mini-review, we present the emerging evidence exploring whether Metformin, GLP-1RA, SGLT2i modulate satellite cell function and if this is a relevant therapeutic target.
Authors
- Chad M. Skiles (ORCID: https://orcid.org/0009-0003-8618-5092)
- Katsuhiko Funai (ORCID: https://orcid.org/0000-0003-3802-4756)
- Edwin R. Miranda (ORCID: https://orcid.org/0000-0003-2370-4118)
- Micah John Drummond (ORCID: https://orcid.org/0000-0001-5961-8890)
Institutions
- University of Utah (US)
Publication Details
- Journal
- American Journal of Physiology-Cell Physiology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1152/ajpcell.90171.2026
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00